FDA Approves New Blood Tests for Alzheimer’s Detection
- Published:
- First detected:
Insights by Echo AI
The FDA has approved multiple blood tests for detecting Alzheimer's disease, including Roche and Eli Lilly's Elecsys pTau217 test and C2N Diagnostics' PrecivityAD2. These tests measure proteins linked to brain amyloid and tau, enabling earlier detection and more accessible evaluation of the disease.
Source coverage
14
records merged
10
8 unique
0
0 unique
4
4 unique
14 Sources
For the first time, new blood test can help detect Alzheimer’s from ag...
FDA Approves First Alzheimer's Blood Test For Americans As Young As 40...
FDA Approves First Alzheimer's Blood Test For Americans As Young As 40...
FDA clears Roche and Eli Lilly's Alzheimer's blood test for primary an...
Unlock Echo Intelligence
Move beyond the public feed. Monitor breaking stories across Telegram, X, and the web — with earlier visibility, clearer context, and complete control over your sources.
- Monitor Telegram, X, and web in one place
- Add any source, from niche channels to global outlets
- Build custom feeds around events, regions, entities, or keywords
- Merge duplicate coverage into one clear, source-transparent story
- Auto-translate summaries and full articles
- Search past coverage and use AI-powered editorial tools
